Weaver Consulting Group

Position in ABBV — AbbVie Inc.

CIK 1780055 HUNTINGTON BEACH, CA

Position in ABBV

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$309,013

+$47,156 QoQ

Shares Held

1,228

+2.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.26%

of 13F equity value

Holder Rank

#3,605

of 4,153 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 26% Shared 0% None 74%

Healthcare · as of Jun 30, 2026

Weaver Consulting Group holds $4,407,808 across 7 Drug Manufacturers - General names. ABBV ranks #6 (7.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	5,013	$1,273,151
2	GILD	Gilead Sciences, Inc.	6,077	$767,768
3	LLY	ELI LILLY & Co	551	$660,885
4	AMGN	Amgen Inc	1,633	$591,341
5	MRK	Merck & Co., Inc.	4,026	$517,341
6	ABBV	AbbVie Inc. This page	1,228	$309,013
7	PFE	Pfizer Inc	11,973	$288,309

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$309,013	1,228	+2.0%	Shares	Sole	2026-07-29
2026-03-31	$261,857	1,204	-0.4%	Shares	Sole	2026-05-15
2025-12-31	$276,244	1,209	+1.2%	Shares	Sole	2026-02-10
2025-09-30	$276,690	1,195	+2.8%	Shares	Sole	2025-11-12
2025-06-30	$215,690	1,162	-8.9%	Shares	Sole	2025-08-12
2025-03-31	$267,347	1,276	-5.4%	Shares	Sole	2025-04-28
2024-12-31	$239,717	1,349	+5.8%	Shares	Sole	2025-01-08
2024-09-30	$251,787	1,275	0.0%	Shares	Sole	2024-11-14
2024-06-30	$218,688	1,275	+2.5%	Shares	Sole	2024-07-12
2022-12-31	$201,042	1,244	-10.9%	Shares	Sole	2023-01-09
2022-03-31	$226,305	1,396	-7.2%	Shares	Sole	2022-05-06
2021-12-31	$203,641	1,504	+167.6%	Shares	Sole	2022-02-01
2020-09-30	$49,225	562	0.0%	Shares	Sole	2020-10-28
2020-06-30	$55,177	562	+64.3%	Shares	Sole	2020-07-24
2020-03-31	$26,056	342	—	Shares	Sole	2020-04-28
No filing history on record for this holder in this stock.